Vitro Biopharma Files Q1 10-Q
| Field | Detail |
|---|---|
| Company | Vitro Biopharma, Inc. |
| Form Type | 10-Q |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biopharma
TL;DR
Vitro Biopharma filed its Q1 10-Q, check financials.
AI Summary
Vitro Biopharma, Inc. filed its 10-Q for the period ending January 31, 2025. The filing covers the first quarter of their fiscal year. The company is involved in biological products, excluding diagnostic substances, and is incorporated in Nevada.
Why It Matters
This filing provides investors with an update on Vitro Biopharma's financial performance and operational status for the first quarter of their fiscal year.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new information presented.
Key Numbers
- 10-Q — Form Type (Standard quarterly report filed with the SEC)
- 20250131 — Fiscal Period End Date (The end date for the financial reporting period)
Key Players & Entities
- Vitro Biopharma, Inc. (company) — Filer of the 10-Q
- 20250131 (date) — End of reporting period
- 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 (address) — Company business and mailing address
- DENVER, CO 80209 (address) — Company business and mailing city, state, and zip
- 8558487627 (phone_number) — Company business phone number
FAQ
What is the primary business of Vitro Biopharma, Inc.?
Vitro Biopharma, Inc. is involved in Biological Products (No Diagnostic Substances), as indicated by its SIC code [2836].
When is Vitro Biopharma's fiscal year end?
Vitro Biopharma's fiscal year ends on October 31st (1031).
What is the SEC file number for Vitro Biopharma?
The SEC file number for Vitro Biopharma is 001-41766.
What is the address of Vitro Biopharma?
Vitro Biopharma's business and mailing address is 3200 CHERRY CREEK DRIVE SOUTH, SUITE 410, DENVER, CO 80209.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending January 31, 2025, which corresponds to the first quarter of their fiscal year.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on March 20, 2025 regarding Vitro Biopharma, Inc..